The Biologics News and Reports Portal

Show Cart

La Merie Publishing

Results 11 - 11 of 11

Aug 2023 Fibroblast Activation Protein (FAP) Targeted Therapy & Companion Diagnostic Pipeline Review

300.00 €

Mar 2023 2022 Sales of Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics

120.00 €

Oct 2021 Masked Antibodies & Cytokines As Prodrugs: a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective

2,250.00 €

Dec 2014 Recombinant Coagulation Factors 2015: Maturation of recombinant clotting factor pipeline and emergence of gene therapy and alternative procoagulants

1,935.00 €

2,150.00 €

(Discount: 10.00%)

Jul 2014 Botulinum Neurotoxins: A comparative industry analysis of products, pipelines, technologies and stakeholders

1,462.50 €

1,950.00 €

(Discount: 25.00%)

Jun 2013 Recombinant Coagulation Factors 2013 – The Race to Market and for Market Shares

2,150.00 €

Mar 2012 Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists - A Target Pipeline and Stakeholder Analysis 2012

1,950.00 €

Oct 2011 Coagulation Factors 2011 – who does meet the market needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis

1,920.00 €

2,400.00 €

(Discount: 20.00%)

Sep 2010 Coagulation Factors 2010 - The Portfolio Aspect as Decisive Force: A Competitive Landscape and R&D Pipeline Analysis of Hemostasis Proteins

2,495.00 €

Aug 2009 Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Analysis

2,450.00 €

Start
Prev
1
2
Next
End

Shopping cart

Cart empty

Shopping cart

Cart empty

Latest report

B7-H3-Targeted Immunotherapy Candidates Pipeline Review

Featured Products

Claudin 18.2-Targeted Immunotherapy: a landscape analysis of stakeholders, drug modalities, pipeline and business opportunities from an industry perspective

CAR-M Industry Landscape Analysis: Chimeric Antigen Receptor-Macrophage (CAR-M) Stakeholders, Technologies, Pipeline, Partnering and Financing

La Merie Publishing

Aug 2023 Fibroblast Activation Protein (FAP) Targeted Therapy & Companion Diagnostic Pipeline Review

Mar 2023 2022 Sales of Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics

Oct 2021 Masked Antibodies & Cytokines As Prodrugs: a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective

Dec 2014 Recombinant Coagulation Factors 2015: Maturation of recombinant clotting factor pipeline and emergence of gene therapy and alternative procoagulants

Jul 2014 Botulinum Neurotoxins: A comparative industry analysis of products, pipelines, technologies and stakeholders

Jun 2013 Recombinant Coagulation Factors 2013 – The Race to Market and for Market Shares

Mar 2012 Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists - A Target Pipeline and Stakeholder Analysis 2012

Oct 2011 Coagulation Factors 2011 – who does meet the market needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis

Sep 2010 Coagulation Factors 2010 - The Portfolio Aspect as Decisive Force: A Competitive Landscape and R&D Pipeline Analysis of Hemostasis Proteins

Aug 2009 Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Analysis

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

La Merie Biologics

FREE Weekly News Bulletin

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing